Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Cleary

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced FibrosisHooman Farhang Zangneh, William W L Wong, Beate Sander, et al.
International Journal of Cancer|August 4, 2016
BRM polymorphisms, pancreatic cancer risk and survivalMaja Segedi, Laura N Anderson, Osvaldo Espin-Garcia, et al.
Journal of the American College of Surgeons|May 22, 2021
Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical TrialJennifer A Yonkus, Roberto Alva-Ruiz, Amro M Abdelrahman, et al.
BMC Surgery|July 29, 2020
Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patientsMichael R Driedger, Carlos A Puig, Cornelius A Thiels, et al.
Nature Structural & Molecular Biology|January 4, 2024
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defenseYuanyuan Li, Zhangfei Shen, Mengyuan Zhang, et al.
Surgery|December 26, 2017
Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 millionChristopher R Shubert, Michael L Kendrick, Elizabeth B Habermann, et al.
Endocrine-Related Cancer|February 11, 2025
Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomaShruti Chandra, Thorvardur R Halfdanarson, Erin E Carlson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Molecular Carcinogenesis|September 12, 2017
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinomaIvan Pasic, Kit M Wong, Jonghun J Lee, et al.
Hepatology (Baltimore, Md.)|May 15, 2016
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation studyGonzalo Sapisochin, Nicolas Goldaracena, Jerome M Laurence, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced FibrosisHooman Farhang Zangneh, William W L Wong, Beate Sander, et al.
International Journal of Cancer|August 4, 2016
BRM polymorphisms, pancreatic cancer risk and survivalMaja Segedi, Laura N Anderson, Osvaldo Espin-Garcia, et al.
Journal of the American College of Surgeons|May 22, 2021
Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical TrialJennifer A Yonkus, Roberto Alva-Ruiz, Amro M Abdelrahman, et al.
BMC Surgery|July 29, 2020
Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patientsMichael R Driedger, Carlos A Puig, Cornelius A Thiels, et al.
Nature Structural & Molecular Biology|January 4, 2024
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defenseYuanyuan Li, Zhangfei Shen, Mengyuan Zhang, et al.
Surgery|December 26, 2017
Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 millionChristopher R Shubert, Michael L Kendrick, Elizabeth B Habermann, et al.
Endocrine-Related Cancer|February 11, 2025
Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomaShruti Chandra, Thorvardur R Halfdanarson, Erin E Carlson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Molecular Carcinogenesis|September 12, 2017
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinomaIvan Pasic, Kit M Wong, Jonghun J Lee, et al.
Hepatology (Baltimore, Md.)|May 15, 2016
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation studyGonzalo Sapisochin, Nicolas Goldaracena, Jerome M Laurence, et al.
Pageof 19